Azevedo, O.G., Oliveira, R.A., Oliveira, B.C., Zaja-Milatovic, S., Araujo, C.V., Wong, D.V., Costa, T.B., Lucena, H.B., Lima Jr., R.C., Ribeiro, R.A., Warren, C.A., Lima, A.A., Vitek, M.P., Guerrant, R.L. and Oria, R.B., 2012. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis. BMC Gastroenterology 12: 35.

'Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis ' () 12 BMC Gastroenterology : 35.

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositisBMC Gastroenterology1235)| false
• Search Google Scholar

Bowen, J.M., Stringer, A.M., Gibson, R.J., Yeoh, A.S., Hannam, S. and Keefe, D.M., 2007. Probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biology and Therapy 6: 1449-1454.

'Probiotic treatment reduces chemotherapy-induced diarrhea and weight loss ' () 6 Cancer Biology and Therapy : 1449 -1454.

Probiotic treatment reduces chemotherapy-induced diarrhea and weight lossCancer Biology and Therapy614491454)| false
• Search Google Scholar

Brenner, D.M. and Chey, W.D. 2009. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome. Reviews in Gastroenterological Disorders 9: 7-15.

'Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome ' () 9 Reviews in Gastroenterological Disorders : 7 -15.

Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndromeReviews in Gastroenterological Disorders9715)| false
• Search Google Scholar

Chang, C.T., Ho, T.Y., Lin, H., Liang, J.A., Huang, H.C., Cheng Li, C.C., Lo, H.Y., Wu, S.L., Huang, Y.F. and Hsiang, C.Y., 2012. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE 7: e31808.

'5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging ' () 7 PLoS ONE : e31808.

5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imagingPLoS ONE7e31808)| false
• Search Google Scholar

Decker-Baumann, C., Buhl, K., Frohmuller, S., Von Herbay, A., Dueck, M. and Schlag, P.M., 1999. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. European Journal of Cancer 35: 202-207.

'Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer ' () 35 European Journal of Cancer : 202 -207.

Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancerEuropean Journal of Cancer35202207)| false
• Search Google Scholar

Howarth, G.S., Tooley, K.L., Davidson, G.P. and Butler, R.N., 2006. A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat. Cancer Biology and Therapy 5: 1189-1195.

'A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat ' () 5 Cancer Biology and Therapy : 1189 -1195.

A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the ratCancer Biology and Therapy511891195)| false
• Search Google Scholar

Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F., Quigley, E.M., Kiely, B., Akdis, C.A. and O’Mahony, L., 2012. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 61: 354-366.

'Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells ' () 61 Gut : 354 -366.

Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cellsGut61354366)| false
• Search Google Scholar

Logan, R.M., Gibson, R.J., Bowen, J.M., Stringer, A.M., Sonis, S.T. and Keefe, D.M., 2008. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemotherapy and Pharmacology 62: 33-41.

'Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis ' () 62 Cancer Chemotherapy and Pharmacology : 33 -41.

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositisCancer Chemotherapy and Pharmacology623341)| false
• Search Google Scholar

O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F. and Quigley, E.M., 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.

'Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles ' () 128 Gastroenterology : 541 -551.

Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profilesGastroenterology128541551)| false
• Search Google Scholar

Shiba, T., Aiba, Y., Ishikawa, H., Ushiyama, A., Takagi, A., Mine, T. and Koga, Y., 2003. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiology and Immunology 47: 371-378.

'The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease ' () 47 Microbiology and Immunology : 371 -378.

The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel diseaseMicrobiology and Immunology47371378)| false
• Search Google Scholar

Sonis, S.T., 2004. The pathobiology of mucositis. Nature Reviews Cancer 4: 277-284.

'The pathobiology of mucositis ' () 4 Nature Reviews Cancer : 277 -284.

The pathobiology of mucositisNature Reviews Cancer4277284)| false
• Search Google Scholar

Sonis, S.T., Elting, L.S., Keefe, D., Peterson, D.E., Schubert, M., Hauer-Jensen, M., Nebiyou Bekele, B., Raber-Durlacher, J., Donnelly, J.P. and Rubenstein, E.B., 2004. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100: 1995-2025.

'Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients ' () 100 Cancer : 1995 -2025.

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patientsCancer10019952025)| false
• Search Google Scholar

Stringer, A.M., Gibson, R.J., Bowen, J.M., Logan, R.M., Yeoh, A.S. and Keefe, D.M., 2007. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. Journal of Supportive Oncology 5: 259-267.

'Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment ' () 5 Journal of Supportive Oncology : 259 -267.

Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environmentJournal of Supportive Oncology5259267)| false
• Search Google Scholar

Tooley, K.L., Howarth, G.S., Lymn, K.A., Lawrence, A. and Butler, R.N., 2006. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate-treated rats. Cancer Biology and Therapy 5: 593-600.

'Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate-treated rats ' () 5 Cancer Biology and Therapy : 593 -600.

Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate-treated ratsCancer Biology and Therapy5593600)| false
• Search Google Scholar

Tsuji, H., Oozeer, R., Matsuda, K., Matsuki, T., Ohta, T., Nomoto, K., Tanaka, R., Kawashima, M., Kawashima, K., Nagata, S. and Yamashiro, Y., 2012. Molecular monitoring of the development of intestinal microbiota in Japanese infants. Beneficial Microbes 3: 113-125.

'Molecular monitoring of the development of intestinal microbiota in Japanese infants ' () 3 Beneficial Microbes : 113 -125.

Molecular monitoring of the development of intestinal microbiota in Japanese infantsBeneficial Microbes3113125)| false
• Search Google Scholar

Xiang, D., Guo, Y., Zhang, J., Gao, J., Lu, H., Zhu, S., Wu, M., Yu, Y. and Han, W., 2011. Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model. Cancer Chemotherapy and Pharmacology 67: 1445-1453.

'Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model ' () 67 Cancer Chemotherapy and Pharmacology : 1445 -1453.

Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine modelCancer Chemotherapy and Pharmacology6714451453)| false
• Search Google Scholar